| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ambrx Biopharma Inc. | Director | Stock Option (right to buy) | 105,000 | 27 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123005792-rupalla-katrin-2023-01-27 | Ambrx Biopharma Inc. | 27 Jan 2023 | 4 | $0 | 4 | Director | 31 Jan 2023, 17:18 |
| ZVSA | ZyVersa Therapeutics, Inc. | 05 Jan 2023 | 0 | $0 | 3 | Director | 17 Jan 2023, 11:59 |
| /report/000120919123000426-rupalla-katrin-2023-01-01 | Ambrx Biopharma Inc. | 01 Jan 2023 | 0 | $0 | 3 | Director | 03 Jan 2023, 17:40 |